Works matching DE "CA 15-3 test"

Results: 32

Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo.

Published in:

JNCI Cancer Spectrum, 2021, v. 5, n. 5, p. 1, doi. 10.1093/jncics/pkab066

By:

Goodwin, Pamela J;
Dowling, Ryan J O;
Ennis, Marguerite;
Chen, Bingshu E;
Parulekar, Wendy R;
Shepherd, Lois E;
Gelmon, Karen A;
Whelan, Timothy J;
Ligibel, Jennifer A;
Hershman, Dawn L;
Mayer, Ingrid A;
Hobday, Timothy J;
Rastogi, Priya;
Rabaglio-Poretti, Manuela;
Lemieux, Julie;
Thompson, Alastair M;
Rea, Daniel W;
Stambolic, Vuk

Publication type:

Article

The role of follow-up CA15-3 in prognosis of breast cancer.

Published in:

European Journal of Gynaecological Oncology, 2025, v. 46, n. 4, p. 19, doi. 10.22514/ejgo.2025.047

By:

Ju-Yeon Kim;
Eun Jung Jung;
Jae-Myung Kim;
Seung-Jin Kwag;
Ji-Ho Park;
Han-Gil Kim;
Taejin Park;
Sang-Ho Jeong;
Chi-Young Jeong;
Young-Tae Ju;
Young-Joon Lee

Publication type:

Article

Determination of the prognostic value of preoperative CA15‑3 and CEA in predicting the prognosis of young patients with breast cancer.

Published in:

Oncology Letters, 2018, v. 16, n. 4, p. 4679, doi. 10.3892/ol.2018.9160

By:

Li, Xuan;
Dai, Danian;
Chen, Bo;
Tang, Hailin;
Xie, Xiaoming;
Wei, Weidong

Publication type:

Article

Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients.

Published in:

Oncology Letters, 2017, v. 14, n. 6, p. 7549, doi. 10.3892/ol.2017.7164

By:

Yue Yang;
Huijuan Zhang;
Mingyan Zhang;
Qingwei Meng;
Li Cai;
Qingyuan Zhang

Publication type:

Article

Comparison of autogeneic and allogeneic natural killer cells immunotherapy on the clinical outcome of recurrent breast cancer.

Published in:

OncoTargets & Therapy, 2017, v. 10, p. 4273, doi. 10.2147/OTT.S139986

By:

Shuzhen Liang;
Kecheng Xu;
Lizhi Niu;
Xiaohua Wang;
Yingqing Liang;
Mingjie Zhang;
Jibing Chen;
Mao Lin

Publication type:

Article

CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients.

Published in:

BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-356

By:

Incoronato, Mariarosaria;
Mirabelli, Peppino;
Catalano, Onofrio;
Aiello, Marco;
Parente, Chiara;
Soricelli, Andrea;
Nicolai, Emanuele

Publication type:

Article

Comparison of CEA and CA15-3 Markers with Serotonin, Ceruloplasmin and Copper in Breast Cancer Recurrence after Chemotherapy.

Published in:

Archives of Breast Cancer, 2021, v. 8, n. 4, p. 313, doi. 10.32768/abc.202184312-317

By:

Rezaei, Sahar;
Moradi-Sardareh, Hemen;
Ansari, Mohammad-Hasan Khadem;
Kheradmand, Fatemeh

Publication type:

Article

Utility of serum total and free prostate-specific antigen in combination with serum carbohydrate antigen 15-3 and carcinoembryonic antigen in breast tumours.

Published in:

Journal of Clinical & Scientific Research, 2018, v. 7, n. 4, p. 159, doi. 10.4103/JCSR.JCSR_9_19

By:

Swathi, Pyreddy;
Lakshmanna, N.;
Rama, Kanchi;
Bitla A. R.;
Srinivasa Rao, P. V. L. N.;
Narendra, Hulikal;
Mutheeswaraiah, Yootla;
Lakshmi, Amancharla Yadagiri;
Phaneendra, B. V.

Publication type:

Article

Carbohydrate Antigen 19-9 Increases the Predictive Efficiency of a-Fetoprotein for Prognosis of Resected Hepatocellular Carcinoma.

Published in:

American Surgeon, 2018, v. 84, n. 1, p. 80, doi. 10.1177/000313481808400126

By:

LI ZHOU;
JING-AN RUI;
SHAO-BIN WANG;
SHU-GUANG CHEN;
QIANG QU

Publication type:

Article

Interassay Comparison of the Tumor Markers CA125, CA15.3, and CA27.29.

Published in:

Journal of Applied Laboratory Medicine, 2017, p. 17, doi. 10.1373/jalm.2016.021436

By:

Winston-McPherson, Gabrielle N.;
Merrill, Anna E.;
Sheng-Ying Lo;
Hoofnagle, Andrew N.;
Greene, Dina N.

Publication type:

Article

Course of SP-D, YKL-40, CCL18 and CA 15-3 in adult patients hospitalised with community-acquired pneumonia and their association with disease severity and aetiology: A post-hoc analysis.

Published in:

PLoS ONE, 2018, v. 13, n. 1, p. 1, doi. 10.1371/journal.pone.0190575

By:

Spoorenberg, Simone M. C.;
Vestjens, Stefan M. T.;
Voorn, G. P.;
van Moorsel, Coline H. M.;
Meek, Bob;
Zanen, Pieter;
Rijkers, Ger T.;
Bos, Willem Jan W.;
Grutters, Jan C.;
null, null

Publication type:

Article

Metabolomic and proteomic analysis of breast cancer patient samples suggests that glutamate and 12-HETE in combination with CA15-3 may be useful biomarkers reflecting tumour burden.

Published in:

Metabolomics, 2015, v. 11, n. 3, p. 620, doi. 10.1007/s11306-014-0723-1

By:

Dowling, Paul;
Henry, Michael;
Meleady, Paula;
Clarke, Colin;
Gately, Kathy;
O'Byrne, Kenneth;
Connolly, Elizabeth;
Lynch, Vincent;
Ballot, Jo;
Gullo, Giuseppe;
Crown, John;
Moriarty, Michael;
Clynes, Martin

Publication type:

Article

Metal-doped Nanoparticles for Detection of Carbohydrate Antigen 15-3 in Human Serum Using a Sandwich-Type ICP-MS Immunoassay.

Published in:

Bulletin of the Korean Chemical Society, 2016, v. 37, n. 9, p. 1433, doi. 10.1002/bkcs.10884

By:

Jang, Hana;
Lim, H. B.

Publication type:

Article

Comparison of the performance of three cancer antigen (CA) 15-3 immunoassays.

Published in:

Journal of Health Sciences, 2016, v. 6, n. 3, p. 154, doi. 10.17532/jhsci.2016.381

By:

Serdarević, Nafija;
Serdarević, Raif;
Memić, Amra

Publication type:

Article

POSTER SUNUM ÖZETLERİ / POSTER PRESENTATION ABSTRACTS.

Published in:: 2018
Publication type:: Abstract

EVALUATION OF CANCER ANTIGEN 15-3 AND HUMAN EPIDIDYMIS PROTEIN 4 LEVEL IN THE SERUM OF IRAQI WOMEN WITH BREAST TUMORS.

Published in:

Biochemical & Cellular Archives, 2021, v. 21, n. 1, p. 1501

By:

Fae’q, Saja Duraid;
Al-Saeed, Hassan H.

Publication type:

Article

MEASURING ACTIVITY OF ACETYL COA CARBOXYLASE AND SOME BIOCHEMICAL PARAMETERS IN SERUM OF BREAST CANCER IRAQI WOMEN BY TUMOR STAGES.

Published in:

Biochemical & Cellular Archives, 2020, v. 20, n. 2, p. 6115

By:

Gazal, Sabah M.;
Ali, Susan J.;
Habib, Perri S.

Publication type:

Article

STUDY THE RELATIONSHIP BETWEEN VITAMIN D<sub>3</sub> AND CANCER ANTIGEN (CA-15-3) IN SERA OF FEMALE WITH BREAST CANCER IN BAGHDAD CITY, IRAQ.

Published in:

Biochemical & Cellular Archives, 2018, v. 18, p. 1023

By:

Alkazazz, Fatin F.;
Jasam, Hadi H.;
Mahdi, Ahmed R.

Publication type:

Article

An individual reference limit of the serum CEA–TPA–CA 15-3 tumor marker panel in the surveillance of asymptomatic women following surgery for primary breast cancer.

Published in:

Cancer Management & Research, 2018, v. 10, p. 6879, doi. 10.2147/CMAR.S177522

By:

Nicolini, Andrea;
Carpi, Angelo;
Ferrari, Paola;
Morganti, Riccardo;
Mazzotti, Valentina;
Barak, Vivian;
Duffy, Michael J

Publication type:

Article

Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.

Published in:

World Journal of Surgical Oncology, 2018, v. 16, p. 1, doi. 10.1186/s12957-018-1325-6

By:

Imamura, Michiko;
Morimoto, Takashi;
Nomura, Takashi;
Michishita, Shintaro;
Nishimukai, Arisa;
Higuchi, Tomoko;
Fujimoto, Yukie;
Miyagawa, Yoshimasa;
Kira, Ayako;
Murase, Keiko;
Araki, Kazuhiro;
Takatsuka, Yuichi;
Oh, Koshi;
Masai, Yoshikazu;
Akazawa, Kouhei;
Miyoshi, Yasuo

Publication type:

Article

Clinical research on treatment of advanced primary liver cancer with combination of thymosin ɑ1 and arsenic trioxide.

Published in:

Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi, 2015, v. 31, n. 4, p. 564, doi. 10.3969/j.issn.1001-5256.2015.04.021

By:

GAO Chengguang;
CHEN Rixia

Publication type:

Article

The Frequency of CA15-3, CA125, CA19-9 in Patients With Hepatitis B and C.

Published in:

Zahedan Journal of Research in Medical Sciences, 2015, v. 17, n. 5, p. 1, doi. 10.17795/zjrms959

By:

Yeganeh-Amirkande, Somayeh;
Assmar, Mehdi;
Mansour-Ghanaei, Fariborz;
Mozafari-Noor, Amir

Publication type:

Article

Tumor markers assay by the Lumipulse G.

Published in:

Clinical Chemistry & Laboratory Medicine, 2015, v. 53, n. 8, p. e183, doi. 10.1515/cclm-2015-0018

By:

Cosma, Chiara;
Faggian, Diego;
Giunta, Chiara;
Plebani, Mario

Publication type:

Article

CA153 in Breast Secretions as a Potential Molecular Marker for Diagnosing Breast Cancer: A Meta Analysis.

Published in:

PLoS ONE, 2016, v. 11, n. 9, p. 1, doi. 10.1371/journal.pone.0163030

By:

Tang, Shifu;
Wei, Lili;
Sun, Yifan;
Zhou, Fang;
Zhu, Shengbo;
Yang, Renqi;
Huang, Yiyong;
Zhang, Hongyu;
Xu, Hong;
Yang, Jianqing

Publication type:

Article

The prognostic significance of preoperative serum cancer antigen 15-3 levels in endometrial carcinomas.

Published in:

Saudi Medical Journal, 2017, v. 38, n. 11, p. 1096, doi. 10.15537/smj.2017.11.20479

By:

Tas, Emre E.;
Yavuz, Ayse F.

Publication type:

Article

Inappropriate practice in tumor marker requests at a university hospital in Western Saudi Arabia: A 3-year retrospective study.

Published in:

International Journal of Biological Markers, 2020, v. 35, n. 4, p. 35, doi. 10.1177/1724600820971305

By:

Al-Mughales, Jamil A.;
Alahwal, Mahmood Shaheen

Publication type:

Article

New biomarkers in community-acquired pneumonia: Another step in improving outcome prediction.

Published in:

2017

By:

Faverio, Paola;
Sibila, Oriol

Publication type:

Editorial

YKL-40, CCL18 and SP-D predict mortality in patients hospitalized with community-acquired pneumonia.

Published in:

Respirology, 2017, v. 22, n. 3, p. 542, doi. 10.1111/resp.12924

By:

Spoorenberg, Simone M.C.;
Vestjens, Stefan M.T.;
Rijkers, Ger T.;
Meek, Bob;
van Moorsel, Coline H.M.;
Grutters, Jan C.;
Bos, Willem Jan W.

Publication type:

Article

UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR, PLASMINOGEN ACTIVATOR INHIBITOR- 1,EXTRACELLULAR MATRIX METALLOPROTEINASE PROTEIN INDUCER AND CA 15-3ASPOTENTIAL BIOMARKERS FOR DIAGNOSIS AND PROGNOSIS OF PRIMARY BREAST CANCER.

Published in:

Egyptian Journal of Biochemistry & Molecular Biology, 2017, v. 35, n. 1-2, p. 93

By:

Hammad, Wafaa A.;
ElMelegy, Nagla T.;
ElBadre, Hala M.;
El-Dosoky, Reham I.;
Ahmed, Badawy M.

Publication type:

Article

Clinical significance of sCIP2A levels in breast cancer.

Published in:

European Review for Medical & Pharmacological Sciences, 2016, v. 20, n. 1, p. 82

By:

XING, M.-L.;
LU, Y.-F.;
WANG, D.-F.;
ZOU, X.-Y.;
ZHANG, S.-X.;
YUN, Z.

Publication type:

Article

Prognostic Factors and Scoring Model for Survival in Metastatic Biliary Tract Cancer.

Published in:

Cancer Research & Treatment, 2017, v. 49, n. 4, p. 1127, doi. 10.4143/crt.2016.538

By:

Hyung Soon Park;
Ji Soo Park;
You Jin Chun;
Yun Ho Roh;
Jieun Moon;
Hong Jae Chon;
Hye Jin Choi;
Joon Seong Park;
Dong Ki Lee;
Se-Joon Lee;
Dong Sup Yoon;
Hei-Cheul Jeung

Publication type:

Article

Serum cancer antigen 15.3 concentrations in patients with beta-thalassemia minor compared to those with cancer and healthy individuals.

Published in:

Medical Journal of the Islamic Republic of Iran, 2014, v. 28, p. 1

By:

Shahriari, Mahdi;
Haghpanah, Sezaneh;
Eatemadfar, Peyman;
Dehghani, Javad;
Javad, Dehbozorgian;
Bazrafshan, Asghar;
Karimi, Mehran

Publication type:

Article